封面
市场调查报告书
商品编码
1708464

肾臟去神经支配设备市场(依手术类型、最终用户和地区)

Renal Denervation Devices Market, By Procedure Type, By End User, By Region

出版日期: | 出版商: Coherent Market Insights | 英文 138 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球肾臟去神经支配设备市场规模估计为 12.534 亿美元,预计到 2032 年将达到 32.736 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 14.7%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 12.534亿美元
效能数据 2020-2024 预测期 2025-2032
预测期:2025-2032年复合年增长率: 14.70% 2032年价值预测 32.736亿美元
数字。 2025年肾臟去神经支配装置各地区市场占有率(%)
肾臟去神经支配设备市场-IMG1

肾臟去神经支配术是一种微创手术,旨在减少肾臟的交感神经活动。导管穿过动脉进入肾动脉,为肾臟供血。然后它将能量传递到血管壁的神经,以破坏导致高血压的信号。能量可以透过多种方式传递,包括射频消融术、超音波以及最近基于化学物质直接注射或经皮输送系统的新技术。肾臟去神经支配的理论基础是肾臟在血压调节中扮演关键角色的认知。肾神经过度活跃会导致全身血压升高。透过阻断这些过度活跃的神经通路,肾臟去神经支配术可能有助于持续降低其他治疗方法失败患者的血压。这种治疗方法在早期临床试验中显示出良好的前景,但在随后的几次临床试验中却结果不一。儘管如此,该医疗设备仍在继续研究和开发,目前正在进行评估其安全性和有效性的临床试验。

市场动态:

预计肾臟去神经支配设备市场在预测期内(2024-2030 年)将显着成长。多种因素推动了市场成长,包括高血压盛行率的上升。此外,预计创新产品核准的增加也将在预测期内推动市场成长。例如,医疗设备公司 Kalos Medical 获得了 467 万韩元(约 350 万美元)的津贴,用于推进治疗高血压的肾臟去神经支配医疗设备的开发。

本研究的主要特点

  • 本研究报告对全球肾臟去神经支配装置市场进行了详细分析,包括市场规模、预测期(2025-2032 年)的复合年增长率(以 2024 年为基准年)。
  • 它还强调了各个领域的潜在收益成长机会,并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 全球肾臟去神经支配装置市场的主要企业根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行分析。
  • 研究涉及的主要企业包括美敦力、Recor Medical、波士顿科学公司、Kona Medical、Terumo Corporation、雅培和 Ablative Solutions。
  • 本报告的见解将使企业负责人和经营团队能够就未来的产品发布、产品升级、市场扩张和行销策略做出明智的决策。
  • 全球肾臟去神经支配装置市场报告针对行业中的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员可以透过用于分析全球肾臟去神经支配设备市场的各种策略矩阵来更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
  • 急性腔室症候群症候群盛行率不断上升
  • 技术进步
    • 限制因素
  • 复杂的法规结构
    • 机会
  • 新兴经济体尚未开发的潜力
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

4. 全球肾臟去神经支配装置市场-冠状病毒(COVID-19)大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 2020 年至 2032 年全球肾臟去神经支配装置市场(依手术类型)

  • 经皮肾去神经支配术
  • 射频肾去神经支配术
  • 超音波肾去神经支配术
  • 其他的

6. 2020 年至 2032 年全球肾臟去神经支配设备市场(依最终用户划分)

  • 医院
  • 诊所
  • 门诊手术中心
  • 其他的

7. 2020 年至 2032 年全球肾臟去神经支配设备市场(按地区)

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲
  • 南非
  • 中部非洲
  • 北非

第八章 竞争态势

  • Medtronic
  • Recor Medical, Inc.
  • Boston Scientific Corp
  • Kona Medical
  • Terumo Corporation
  • Abbott
  • Ablative Solutions
  • Others

第九章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI798

Global Renal Denervation Devices Market is estimated to be valued at USD 1,253.4 Mn in 2025 and is expected to reach USD 3,273.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 14.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1,253.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 14.70% 2032 Value Projection: USD 3,273.6 Mn
Figure. Renal Denervation Devices Market Share (%), By Region 2025
Renal Denervation Devices Market - IMG1

Renal denervation is a minimally invasive procedure that aims to decrease the sympathetic nerve activity to the kidneys. It involves threading a catheter through the arteries until it reaches the renal arteries, which supplies blood to the kidneys. The device then delivers energy to the nerves in the vessel wall to disrupt the signals that can cause high blood pressure. The energy can be delivered through various methods, such as radiofrequency ablation, ultrasound, and more recently, direct injection of chemicals or new methodologies based on percutaneous delivery systems. The rationale behind renal denervation comes from the understanding that the kidneys play a significant role in blood pressure regulation. Overactive renal nerves can lead to increased systemic blood pressure. By disrupting these overactive nerve pathways, renal denervation can potentially help to sustainably lower blood pressure in people for whom other treatments have failed. Although the procedure showed promise in early clinical trials, some subsequent trials had mixed results, which led to further investigations to better understand the patient populations that may benefit and to optimize the technique. Nonetheless, the devices continue to be studied and developed, with ongoing clinical trials evaluating their safety and efficacy.

Market Dynamics:

The renal denervation devices market is expected to witness significant growth during the forecast period (2024-2030). Several factors contribute to the market growth including the rising prevalence of hypertension. Additionally, the increasing approval of innovative products is expected to propel the market growth over the forecast period. For instance, Kalos Medical, a medical device company, received a grant of Won4.67m (approximately $3.5m) to advance the development of its renal denervation medical device to treat hypertension.

Key Features of the Study:

  • This report provides an in-depth analysis of the global renal denervation devices market, including market size (in US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), with 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • Key players in the global renal denervation devices market are profiled based on parameters such as company highlights, product portfolio, key highlights, financial performance, and strategies
  • Key companies covered in this study include Medtronic, Recor Medical, Inc., Boston Scientific Corp, Kona Medical, Terumo Corporation, Abbott, Ablative Solutions, and others
  • Insights from this report would enable marketers and management authorities of companies to make informed decisions regarding future product launches, product upgrades, market expansion, and marketing tactics.
  • The global renal denervation devices market report caters to various stakeholders in the industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global renal denervation devices market

Renal Denervation Devices Market Segmentation

  • By Procedure Type
    • Percutaneous Renal Denervation
    • Radiofrequency Renal Denervation
    • Ultrasound Renal Denervation
    • Others
  • By End User
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Medtronic
    • Recor Medical, Inc
    • Boston Scientific Corp
    • Kona Medical
    • Terumo Corporation
    • Abbott
    • Ablative Solutions
    • Others

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Procedure Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing prevalence of acute compartment syndrome
  • Technological Advancement
    • Restraints
  • Complex Regulatory Framework
    • Opportunities
  • Untapped Potential in the Emerging Economies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Renal Denervation Devices Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Renal Denervation Devices Market , By Procedure Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Percutaneous Renal Denervation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Radiofrequency Renal Denervation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Ultrasound Renal Denervation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Renal Denervation Devices Market , By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

7. Global Renal Denervation Devices Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • China
      • Japan
      • India
      • Australia
      • ASEAN
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2020-2032,(US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

8. Competitive Landscape

  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Recor Medical, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boston Scientific Corp
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Kona Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ablative Solutions
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Others
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us